ZEO ScientifiX Advances to Semi-Finals of XPRIZE Healthspan Competition
ZEO ScientifiX has been selected as a qualified team advancing to the semi-finals stage of the XPRIZE Healthspan competition. The announcement confirms the company’s inclusion among teams progressing in the global contest, which aims to accelerate breakthroughs in extending human healthspan and improving quality of life during aging.
The XPRIZE Healthspan competition challenges participants to develop innovative solutions that enhance longevity and health outcomes. ZEO ScientifiX, listed on OTCQB under the ticker symbol ZEOX, is now positioned to compete further in this initiative. Teams selected for the semi-finals undergo rigorous evaluation based on their proposed methodologies, scientific approaches, and potential impact on human health. This advancement signifies recognition of ZEO ScientifiX’s efforts within this competitive field. Further updates regarding subsequent stages are expected as the competition progresses.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 7, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]






